New guidelines for hypertrophic cardiomyopathy: the impact on prophylactic cardioverter-defibrillator implantation

被引:0
|
作者
Godinho, A. R. [1 ]
Vasconcelos, M. [1 ]
Rangel, I. [1 ]
Araujo, V. [1 ]
Frutuoso, C. [1 ]
Cardoso, J. S. C. [1 ]
Maciel, M. J. [1 ]
机构
[1] Univ Porto, Cardiol, P-4100 Oporto, Portugal
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
P1460
引用
收藏
页码:307 / 307
页数:1
相关论文
共 50 条
  • [21] The Implantable cardioverter-defibrillator and hypertrophic cardiomyopathy.: Experience at three centers
    Marin, Francisco
    Gimeno, Juan R.
    Paya, Eduardo
    Garcia-Alberola, Arcadio
    Perez-Alvarez, Luisa
    Fernandez, Xusto
    de la Morena, Gonzalo
    Sogorb, Francisco
    Castro-Beiras, Alfonso
    Valdes, Mariano
    Martinez, Juan G.
    Monserrat, Lorenzo
    REVISTA ESPANOLA DE CARDIOLOGIA, 2006, 59 (06): : 537 - 544
  • [22] Clinical Impact of Nonsustained Ventricular Tachycardia Recorded by the Implantable Cardioverter-Defibrillator in Patients with Hypertrophic Cardiomyopathy
    Francia, Pietro
    Santini, Daria
    Musumeci, Beatrice
    Semprini, Lorenzo
    Adduci, Carmen
    Pagannone, Erika
    Proietti, Giulia
    Volpe, Massimo
    Autore, Camillo
    JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY, 2014, 25 (11) : 1180 - 1187
  • [23] Outcome of hypertrophic cardiomyopathy associated with sarcomere protein gene mutations: impact of the implantable cardioverter-defibrillator
    Tomberli, B.
    Ferrantini, C.
    Coppini, R.
    Girolami, F.
    Castelli, G.
    Fornaro, A.
    Pieragnoli, P.
    Olivotto, I.
    Padeletti, L.
    Cecchi, F.
    EUROPEAN HEART JOURNAL, 2013, 34 : 166 - 166
  • [24] A prophylactic implantable cardioverter-defibrillator? Discussion
    Bourke
    Brugada
    Crick
    Kuck
    Rosenqvist
    AMERICAN JOURNAL OF CARDIOLOGY, 1996, 78 : 133 - 133
  • [25] Hypertrophic cardiomyopathy and sudden death: new perspectives on risk stratification and prevention with the implantable cardioverter-defibrillator
    Maron, BJ
    EUROPEAN HEART JOURNAL, 2000, 21 (24) : 1979 - 1983
  • [26] Survival Following Implantable Cardioverter-Defibrillator Implantation in Patients With Amyloid Cardiomyopathy
    Higgins, Angela Y.
    Annapureddy, Amarnath R.
    Wang, Yongfei
    Minges, Karl E.
    Lampert, Rachel
    Rosenfeld, Lynda E.
    Jacoby, Daniel L.
    Curtis, Jeptha P.
    Miller, Edward J.
    Freeman, James V.
    JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2020, 9 (18):
  • [27] Clinical outcome following cardioverter defibrillator implantation in patients with hypertrophic cardiomyopathy
    Lobo, TJ
    Friedman, PA
    Rea, RF
    Munger, TM
    Hammill, SC
    Osborn, MJ
    Packer, DL
    Stanton, MS
    Shen, WK
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1998, 31 (02) : 435A - 435A
  • [28] Implantable cardioverter-defibrillator in hypertrophic cardiomyopathy. Data from a multicenter registry
    Marin Ortuno, F.
    Martinez, J. G.
    Berruezo, A.
    Pedrote, A.
    Galve, E.
    Fernandez, S.
    Garcia Lozano, I.
    Moro, C.
    Peinado, R.
    Monserrat, L.
    EUROPEAN HEART JOURNAL, 2008, 29 : 311 - 311
  • [29] Advantages of a Subcutaneous Implantable Cardioverter-Defibrillator in LAMP2 Hypertrophic Cardiomyopathy
    Zaki, Aly
    Zaidi, Amir
    Newman, William G.
    Garratt, Clifford J.
    JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY, 2013, 24 (09) : 1051 - 1053
  • [30] Implantable Cardioverter-defibrillator Therapy for Hypertrophic Cardiomyopathy: Usefulness in Primary and Secondary Prevention
    Sarrias, Axel
    Galve, Enrique
    Sabate, Xavier
    Moya, Angel
    Anguera, Ignacio
    Nunez, Elaine
    Villuendas, Roger
    Alcalde, Oscar
    Garcia-Dorado, David
    REVISTA ESPANOLA DE CARDIOLOGIA, 2015, 68 (06): : 492 - 496